Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Gluten
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Pathophysiological research=== The gluten [[peptide]]s are responsible for triggering gluten-related disorders.<ref name=LammersHerrera2018 /> In people who have celiac disease, the peptides trigger an immune response that causes injury of the intestines, ranging from [[inflammation]] to partial or total destruction of the [[intestinal villus|intestinal villi]].<ref name=DicksonStreutker2006>{{cite journal| vauthors=Dickson BC, Streutker CJ, Chetty R| title=Coeliac disease: an update for pathologists | journal=J Clin Pathol | year= 2006 | volume= 59 | issue= 10 | pages= 1008β16 | pmid=17021129 | doi=10.1136/jcp.2005.035345 | pmc=1861744 | type=Review }}</ref><ref name=StovenMurray2013 /> To study mechanisms of this damage, laboratory experiments are done ''in vitro'' and ''in vivo''.<ref name=KupferJabri2012>{{cite journal| vauthors=Kupfer SS, Jabri B| title=Pathophysiology of celiac disease | journal=Gastrointest Endosc Clin N Am | year= 2012 | volume= 22 | issue= 4 | pages= 639β60 | pmid=23083984 | doi=10.1016/j.giec.2012.07.003 | pmc=3872820 |type=Review }}</ref><ref name=StovenMurray2013>{{cite journal| vauthors=Stoven S, Murray JA, Marietta EV| title=Latest in vitro and in vivo models of celiac disease | journal=Expert Opin Drug Discov | year= 2013 | volume= 8 | issue= 4 | pages= 445β57 | pmid=23293929 | doi=10.1517/17460441.2013.761203 | pmc=3605231 |type=Review }}</ref> Among the gluten peptides, [[gliadin]] has been studied extensively.<ref name=LammersHerrera2018 /> ====''In vitro'' and ''in vivo'' studies==== In the context of celiac disease, [[Gliadin|gliadin peptides]] are classified in [[basic research|basic]] and [[clinical research]] as [[Immunogenicity|immunogenic]], depending on their [[mechanism of action]]:<ref name=LammersHerrera2018>{{cite journal| vauthors=Lammers KM, Herrera MG, Dodero VI| title=Translational Chemistry Meets Gluten-Related Disorders | journal=ChemistryOpen | year= 2018 | volume= 7 | issue= 3 | pages= 217β232 | pmid=29531885 | doi=10.1002/open.201700197 | pmc=5838388 | type=Review }}</ref><ref name=SilanoVincentini2009>{{cite journal| vauthors=Silano M, Vincentini O, De Vincenzi M| title=Toxic, immunostimulatory and antagonist gluten peptides in celiac disease | journal=Curr Med Chem | year= 2009 | volume= 16 | issue= 12 | pages= 1489β98 | pmid=19355902 | type=Review | doi=10.2174/092986709787909613 }}</ref> * The peptides are those capable of directly affecting cells and intestinal preparations ''in vitro'', producing cellular damage ''in vivo'' and eliciting the innate immune response.<ref name=LammersHerrera2018 /><ref name=SilanoVincentini2009 /> ''In vitro'', the peptides promote cell [[apoptosis]] (a form of [[programmed cell death]]) and inhibit the synthesis of [[nucleic acid]]s (DNA and RNA) and proteins, reducing the viability of cells.<ref name=ElliRoncoroni2015 /> Experiments ''in vivo'' with normal mice showed that they cause an increase in cell death and the production of [[interferon type I]] (an inflammatory mediator).<ref name=LammersHerrera2018 /> ''In vitro'', gluten alters cellular [[morphology (biology)|morphology]] and [[motility]], [[cytoskeleton]] organization, [[redox|oxidative balance]], and [[tight junction]]s.<ref name=Fasano2011>{{cite journal | author = Fasano A | date = Jan 2011 | title = Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer | journal = Physiol. Rev. | volume = 91 | issue = 1| pages = 151β75 | doi = 10.1152/physrev.00003.2008 | pmid = 21248165 | type = Review| citeseerx = 10.1.1.653.3967 | quote= There are at least 50 toxic epitopes in gluten peptides exerting cytotoxic, immunomodulatory, and gut-permeating activities. }}</ref><ref name=ElliRoncoroni2015>{{cite journal| vauthors=Elli L, Roncoroni L, Bardella MT| title=Non-celiac gluten sensitivity: Time for sifting the grain | journal=World J Gastroenterol | year= 2015 | volume= 21 | issue= 27 | pages= 8221β6 | pmid=26217073 | doi=10.3748/wjg.v21.i27.8221 | pmc=4507091 | type=Review | doi-access=free }}</ref><ref name=LeonardSapone2017 /> * The immunogenic peptides are those able to activate [[T cell]]s ''in vitro''.<ref name=LammersHerrera2018 /> At least 50 [[epitope]]s of gluten may produce cytotoxic, immunomodulatory, and [[intestinal permeability|gut-permeating]] activities.<ref name=Fasano2011 /> The effect of oat peptides (avenins) in celiac people depends on the oat [[cultivar]] consumed because of prolamin genes, protein amino acid sequences, and the immunotoxicity of prolamins which vary among oat varieties.<ref name=PenaginiDilillo>{{cite journal | vauthors = Penagini F, Dilillo D, Meneghin F, Mameli C, Fabiano V, Zuccotti GV| title = Gluten-free diet in children: an approach to a nutritionally adequate and balanced diet | journal = Nutrients | volume = 5| issue = 11| pages = 4553β65| date = Nov 18, 2013| pmid = 24253052|pmc= 3847748| doi = 10.3390/nu5114553| type=Review| doi-access = free }}</ref><ref name=DeSouzaDeschenes2016>{{cite journal| vauthors=de Souza MC, DeschΓͺnes ME, Laurencelle S, Godet P, Roy CC, Djilali-Saiah I| title=Pure Oats as Part of the Canadian Gluten-Free Diet in Celiac Disease: The Need to Revisit the Issue | journal=Can J Gastroenterol Hepatol | year= 2016 | volume= 2016 | pages= 1β8 | pmid=27446824 | doi=10.1155/2016/1576360 | pmc=4904650 | type= Review | doi-access=free }}</ref><ref name=CominoMoreno2015>{{cite journal | vauthors = Comino I, Moreno Mde L, Sousa C | title = Role of oats in celiac disease | journal = World J Gastroenterol | volume = 21 | issue = 41 | pages = 11825β31 | date = Nov 7, 2015 | pmid = 26557006 |pmc= 4631980 | doi = 10.3748/wjg.v21.i41.11825 |quote= It is necessary to consider that oats include many varieties, containing various amino acid sequences and showing different immunoreactivities associated with toxic prolamins. As a result, several studies have shown that the immunogenicity of oats varies depending on the cultivar consumed. Thus, it is essential to thoroughly study the variety of oats used in a food ingredient before including it in a gluten-free diet. | doi-access = free }}</ref> In addition, oat products may be cross-contaminated with the other gluten-containing [[cereal]]s.<ref name="DeSouzaDeschenes2016"/>
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Gluten
(section)
Add topic